Literature DB >> 25987251

Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.

Arick C Park1, Charlotte L Phillips2, Ferris M Pfeiffer2, Drew A Roenneburg3, John F Kernien1, Sheila M Adams4, Jeffrey M Davidson5, David E Birk4, Daniel S Greenspan6.   

Abstract

Null alleles for the COL5A1 gene and missense mutations for COL5A1 or the COL5A2 gene underlie cases of classic Ehlers-Danlos syndrome, characterized by fragile, hyperextensible skin and hypermobile joints. However, no classic Ehlers-Danlos syndrome case has yet been associated with COL5A2 null alleles, and phenotypes that might result from such alleles are unknown. We describe mice with null alleles for the Col5a2. Col5a2(-/-) homozygosity is embryonic lethal at approximately 12 days post conception. Unlike previously described mice null for Col5a1, which die at 10.5 days post conception and virtually lack collagen fibrils, Col5a2(-/-) embryos have readily detectable collagen fibrils, thicker than in wild-type controls. Differences in Col5a2(-/-) and Col5a1(-/-) fibril formation and embryonic survival suggest that α1(V)3 homotrimers, a rare collagen V isoform that occurs in the absence of sufficient levels of α2(V) chains, serve functional roles that partially compensate for loss of the most common collagen V isoform. Col5a2(+/-) adults have skin with marked hyperextensibility and reduced tensile strength at high strain but not at low strain. Col5a2(+/-) adults also have aortas with increased compliance and reduced tensile strength. Results thus suggest that COL5A2(+/-) humans, although unlikely to present with frank classic Ehlers-Danlos syndrome, are likely to have fragile connective tissues with increased susceptibility to trauma and certain chronic pathologic conditions.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25987251      PMCID: PMC4483463          DOI: 10.1016/j.ajpath.2015.03.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Identification of an upstream regulatory region essential for cell type-specific transcription of the pro-alpha 2(V) collagen gene (COL5A2).

Authors:  S Truter; M Di Liberto; Y Inagaki; F Ramirez
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

2.  Homology between alpha 2(V) and alpha 1(III) collagen promoters and evidence for negatively acting elements in the alpha 2(V) first intron and 5' flanking sequences.

Authors:  D S Greenspan; S T Lee; B S Lee; G G Hoffman
Journal:  Gene Expr       Date:  1991-04

3.  High levels of expression of full length human pro-alpha 2(V) collagen cDNA in pro-alpha 2(V)-deficient hamster cells.

Authors:  D S Greenspan; G G Hoffman; B S Lee
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

4.  Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins.

Authors:  L W Fisher; J T Stubbs; M F Young
Journal:  Acta Orthop Scand Suppl       Date:  1995-10

Review 5.  Another look at collagen V and XI molecules.

Authors:  A Fichard; J P Kleman; F Ruggiero
Journal:  Matrix Biol       Date:  1995-07       Impact factor: 11.583

6.  Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly.

Authors:  K Andrikopoulos; X Liu; D R Keene; R Jaenisch; F Ramirez
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

7.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

8.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

9.  Cooperative interactions between PBX, PREP, and HOX proteins modulate the activity of the alpha 2(V) collagen (COL5A2) promoter.

Authors:  D Penkov; S Tanaka; G Di Rocco; J Berthelsen; F Blasi; F Ramirez
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

10.  Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter.

Authors:  D E Birk; J M Fitch; J P Babiarz; K J Doane; T F Linsenmayer
Journal:  J Cell Sci       Date:  1990-04       Impact factor: 5.285

View more
  12 in total

1.  Deficits in Col5a2 Expression Result in Novel Skin and Adipose Abnormalities and Predisposition to Aortic Aneurysms and Dissections.

Authors:  Arick C Park; Noel Phan; Dawiyat Massoudi; Zhenjie Liu; John F Kernien; Sheila M Adams; Jeffrey M Davidson; David E Birk; Bo Liu; Daniel S Greenspan
Journal:  Am J Pathol       Date:  2017-07-19       Impact factor: 4.307

Review 2.  The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution.

Authors:  Aaron L Fidler; Sergei P Boudko; Antonis Rokas; Billy G Hudson
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

Review 3.  Genes Associated with Thoracic Aortic Aneurysm and Dissection: An Update and Clinical Implications.

Authors:  Adam J Brownstein; Bulat A Ziganshin; Helena Kuivaniemi; Simon C Body; Allen E Bale; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2017-02-01

4.  Increased Collagen Type V α2 (COL5A2) in Colorectal Cancer is Associated with Poor Prognosis and Tumor Progression.

Authors:  Jie Wang; Ying-Hua Jiang; Peng-Yuan Yang; Feng Liu
Journal:  Onco Targets Ther       Date:  2021-05-05       Impact factor: 4.147

5.  Genes Associated with Thoracic Aortic Aneurysm and Dissection: 2019 Update and Clinical Implications.

Authors:  Thais Faggion Vinholo; Adam J Brownstein; Bulat A Ziganshin; Mohammad A Zafar; Helena Kuivaniemi; Simon C Body; Allen E Bale; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2019-12-16

6.  COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.

Authors:  Yun-Long Ding; Shu-Fang Sun; Guang-Liang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

7.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

8.  Genes Associated with Thoracic Aortic Aneurysm and Dissection: 2018 Update and Clinical Implications.

Authors:  Adam J Brownstein; Valentyna Kostiuk; Bulat A Ziganshin; Mohammad A Zafar; Helena Kuivaniemi; Simon C Body; Allen E Bale; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2018-07-27

9.  The Transcription Factor HAND1 Is Involved in Cortical Bone Mass through the Regulation of Collagen Expression.

Authors:  Noriko Funato; Yuki Taga; Lindsay E Laurie; Chisa Tometsuka; Masashi Kusubata; Kiyoko Ogawa-Goto
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

10.  Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis.

Authors:  Biao Yang; Meijing Zhang; Tianhang Luo
Journal:  Front Genet       Date:  2020-10-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.